Matinas Biopharma Holdings Inc. (MTNB) Fell -14.77% or -0.17 To Price $0.98 On Wednesday


Matinas Biopharma Holdings Inc. (MTNB) fell -14.77% or -0.17 to $0.98. It is near 514449 shares traded, which is 294.05% compare to the average total volume 174950. The market cap of MTNB is $91.10 million. The year to date change is -7.26%. The 52 week price range is from $0.98 to $3.99. Price of MTNB have changed -0.86% during last week. It have changed -7.26% over last month, 1.77% over last 3 months, 2.68% over last 6 months and -47.25% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MTNB is 1.30. It is 32.65% above current price. The 200-day Moving Averages for MTNB is 1.69. It is 72.45% above current price. The 52-week High is 3.99. It is 307.14% from the current price. The 52-week Low is 0.98. The stock hits 52-week low today.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MTNB is 6.26 on 2018-01-12. Short % to float is 1.66%. There are some statistics of MTNB. It is has market cap $91.10 million. The share outstanding is 92.95 million. The average volume is 174950. The percent of top 15 Institution holding is 14.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MTNB is -634.58%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MTNB is -219.53%.


Tags:

Share this post